Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Network Pharmacology Analysis to Identify Phytochemicals in Traditional Chinese Medicines That May Regulate ACE2 for the Treatment of COVID‐19
Wenhao Niu, Feng Wu, Haiming Cui, et al.
Evidence-based Complementary and Alternative Medicine (2020) Vol. 2020, Iss. 1
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Traditional Chinese Medicine (TCM) in the treatment of COVID-19 and other viral infections: Efficacies and mechanisms
Kai Huang, Pan Zhang, H. H. Zhang, et al.
Pharmacology & Therapeutics (2021) Vol. 225, pp. 107843-107843
Open Access | Times Cited: 398
Flavonoids against the SARS-CoV-2 induced inflammatory storm
Alena Líšková, Marek Samec, Lenka Koklesová, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 138, pp. 111430-111430
Open Access | Times Cited: 138
Bioactive compounds from Huashi Baidu decoction possess both antiviral and anti-inflammatory effects against COVID-19
Haiyu Xu, Shufen Li, Jiayuan Liu, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 18
Open Access | Times Cited: 81
Epigenetic underpinnings of inflammation: Connecting the dots between pulmonary diseases, lung cancer and COVID-19
Shama Ahmad, Shajer Manzoor, Sazia Siddiqui, et al.
Seminars in Cancer Biology (2021) Vol. 83, pp. 384-398
Open Access | Times Cited: 76
Review on the Diverse Biological Effects of Glabridin
Jianhong Zhang, Xinhui Wu, Baiyin Zhong, et al.
Drug Design Development and Therapy (2023) Vol. Volume 17, pp. 15-37
Open Access | Times Cited: 40
Role of microRNAs in COVID-19 with implications for therapeutics
Nahid Arghiani, Tracy Nissan, Maryam Moghaddam Matin
Biomedicine & Pharmacotherapy (2021) Vol. 144, pp. 112247-112247
Open Access | Times Cited: 54
Screening S protein – ACE2 blockers from natural products: Strategies and advances in the discovery of potential inhibitors of COVID-19
Le-le Ma, Huimin Liu, Xuemei Liu, et al.
European Journal of Medicinal Chemistry (2021) Vol. 226, pp. 113857-113857
Open Access | Times Cited: 33
Composition, Clinical Efficiency, and Mechanism of NHC-Approved “Three Chinese Medicines and Three Chinese Recipes” for COVID-19 Treatment
Ke-Yao Xia, Zeyuan Zhao, Taif Shah, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 27
Chinese Medicine Formula Huashibaidu Granule Early Treatment for Mild COVID-19 Patients: An Unblinded, Cluster-Randomized Clinical Trial
Zhao Chen, Li Li, Wei Yang, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 29
miRNAs: The Key Regulator of COVID-19 Disease
Leyla Tahrani Hardin, Nan Xiao
International Journal of Cell Biology (2022) Vol. 2022, pp. 1-19
Open Access | Times Cited: 20
Gallic acid and hesperidin elevate neurotransmitters level and protect against oxidative stress, inflammation and apoptosis in aluminum chloride-induced Alzheimer's disease in rats
Bidemi Emmanuel Ekundayo, Tajudeen Olabisi Obafemi, Blessing A. Afolabi, et al.
Pharmacological Research - Modern Chinese Medicine (2022) Vol. 5, pp. 100193-100193
Open Access | Times Cited: 19
SARS-CoV-2-associated organs failure and inflammation: a focus on the role of cellular and viral microRNAs
Reyhaneh Rasizadeh, Parisa Shiri Aghbash, Javid Sadri Nahand, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 7
The Role of Ursodeoxycholic Acid Administration During the COVID‐19 Pandemic: A Questionnaire Survey
Cheng Zhou, Ran Jia, Jinqiu Yang, et al.
Canadian Journal of Infectious Diseases and Medical Microbiology (2025) Vol. 2025, Iss. 1
Open Access
Targeting Neurological Manifestations of Coronaviruses by Candidate Phytochemicals: A Mechanistic Approach
Sajad Fakhri, Sana Piri, Mohammad Bagher Majnooni, et al.
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 21
Herbal Medicine, Gut Microbiota, and COVID-19
Ziqi Chen, Yiwen Lv, Huachong Xu, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 20
Efficacy and safety of chinese herbal medicine for treating mild or moderate COVID-19: A systematic review and meta-analysis of randomized controlled trials and observational studies
Hongfei Zhu, Mengting Li, Chen Tian, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 13
Treatment Effect of Qingfei Paidu Decoction Combined With Conventional Treatment on COVID-19 Patients and Other Respiratory Diseases: A Multi-Center Retrospective Case Series
Xingyu Zong, Ning Liang, Jingya Wang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 12
Effect and mechanism of quercetin or quercetin‐containing formulas against COVID‐19: From bench to bedside
Jhong Yuan Chen, Tsung Rung Huang, Shih Yun Hsu, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 6, pp. 2597-2618
Closed Access | Times Cited: 2
Research status of Chinese medicine formula based on network pharmacology
Zhenghui Pan, Mengqian Li, Zhiyu Jin, et al.
Pharmacological Research - Modern Chinese Medicine (2022) Vol. 4, pp. 100132-100132
Open Access | Times Cited: 10
Deciphering suppressive effects of Lianhua Qingwen Capsule on COVID-19 and synergistic effects of its major botanical drug pairs
Yuanyuan CHEN, Cheng Zhang, Ning Wang, et al.
Chinese Journal of Natural Medicines (2023) Vol. 21, Iss. 5, pp. 383-400
Open Access | Times Cited: 6
Research Progress of Immunomodulation on Anti-COVID-19 and the Effective Components from Traditional Chinese Medicine
Ting Hu, Li Li, Qin Ma
The American Journal of Chinese Medicine (2023) Vol. 51, Iss. 06, pp. 1337-1360
Closed Access | Times Cited: 5
“Three medicines and three formulas” in COVID-19: from bench to bedside
Guangxu Xiao, Simeng Wang, Ruijiao Wang, et al.
Acupuncture and Herbal Medicine (2023) Vol. 3, Iss. 4, pp. 309-322
Open Access | Times Cited: 5
G protein-coupled receptors and traditional Chinese medicine: new thinks for the development of traditional Chinese medicine
Ting Zhang, Wenqiao An, Sheng‐Jie You, et al.
Chinese Medicine (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1
Food-Derived Up-Regulators and Activators of Angiotensin Converting Enzyme 2: A Review
Z. Wang, Hongbing Fan, Jianping Wu
Journal of Agricultural and Food Chemistry (2024) Vol. 72, Iss. 23, pp. 12896-12914
Open Access | Times Cited: 1
Harnessing traditional Chinese medicine polysaccharides for combatting COVID-19
Zhiyong Xiao, Yizhen Guo, Jingxuan Li, et al.
Carbohydrate Polymers (2024) Vol. 346, pp. 122605-122605
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top